| Primary |
| Testis Cancer |
38.5% |
| Retinoblastoma |
24.6% |
| Retinoblastoma Bilateral |
12.3% |
| Testicular Cancer Metastatic |
10.8% |
| Extragonadal Primary Germ Cell Cancer |
9.2% |
| Ovarian Neoplasm |
4.6% |
|
| Pulmonary Fibrosis |
26.7% |
| Azoospermia |
13.3% |
| Bone Sarcoma |
13.3% |
| Interstitial Lung Disease |
13.3% |
| Myalgia |
6.7% |
| Neutropenia |
6.7% |
| Treatment Related Secondary Malignancy |
6.7% |
| Tumour Lysis Syndrome |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
|
| Secondary |
| Adult T-cell Lymphoma/leukaemia |
14.0% |
| Lymphoma |
13.5% |
| Drug Use For Unknown Indication |
12.9% |
| Stem Cell Transplant |
7.4% |
| Testicular Neoplasm |
6.4% |
| Rhabdomyosarcoma |
4.2% |
| Product Used For Unknown Indication |
3.9% |
| Acute Myeloid Leukaemia Recurrent |
3.5% |
| Bone Sarcoma |
3.5% |
| Lung Neoplasm Malignant |
3.5% |
| B-cell Lymphoma |
3.4% |
| Acute Lymphocytic Leukaemia |
3.2% |
| Testicular Choriocarcinoma Stage Iii |
3.2% |
| Chemotherapy |
2.8% |
| Constipation |
2.8% |
| Febrile Neutropenia |
2.7% |
| Cancer Pain |
2.5% |
| Medulloblastoma |
2.3% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Neuroblastoma |
2.1% |
|
| Sepsis |
12.5% |
| Thrombocytopenia |
11.3% |
| Pneumonia |
10.0% |
| White Blood Cell Count Decreased |
10.0% |
| Acute Myeloid Leukaemia |
6.3% |
| Interstitial Lung Disease |
5.0% |
| Azoospermia |
3.8% |
| Diarrhoea |
3.8% |
| Febrile Neutropenia |
3.8% |
| Renal Failure |
3.8% |
| Splenic Infarction |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Vomiting |
3.8% |
| Encephalopathy |
2.5% |
| Ileus |
2.5% |
| Metastases To Lung |
2.5% |
| Mucous Membrane Disorder |
2.5% |
| Myelodysplastic Syndrome |
2.5% |
| Pancytopenia |
2.5% |
|
| Concomitant |
| Allogenic Bone Marrow Transplantation Therapy |
15.4% |
| Immunosuppression |
9.8% |
| Chronic Myeloid Leukaemia |
7.9% |
| Prophylaxis |
7.9% |
| Stem Cell Transplant |
7.1% |
| Myelodysplastic Syndrome |
5.9% |
| Infection Prophylaxis |
5.1% |
| Non-hodgkin's Lymphoma |
4.3% |
| Lymphoma |
3.9% |
| Neoplasm Malignant |
3.9% |
| Rhabdomyosarcoma |
3.9% |
| Sepsis |
3.5% |
| Acute Myeloid Leukaemia |
3.1% |
| Cough |
3.1% |
| Histiocytosis Haematophagic |
3.1% |
| Bone Sarcoma |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.4% |
| Febrile Neutropenia |
2.4% |
| Hepatitis C |
2.4% |
| Mantle Cell Lymphoma Stage Iv |
2.4% |
|
| Cardiomyopathy |
8.2% |
| Neutropenia |
8.2% |
| Pleural Effusion |
8.2% |
| Vitamin K Deficiency |
8.2% |
| White Blood Cell Count Decreased |
8.2% |
| Cardiac Failure |
4.1% |
| Encephalopathy |
4.1% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
4.1% |
| Inappropriate Antidiuretic Hormone Secretion |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Liver Disorder |
4.1% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
4.1% |
| Pulmonary Alveolar Haemorrhage |
4.1% |
| Red Blood Cell Count Decreased |
4.1% |
| Renal Disorder |
4.1% |
| Renal Failure Acute |
4.1% |
| Renal Impairment |
4.1% |
| Shock |
4.1% |
| Tremor |
4.1% |
| Acute Leukaemia |
2.0% |
|
